PatternsRadar
Sign in

METROPOLISMetropolis Healthcare Limited

NSE
Full chart
552.65INR-0.95 (-0.17%)Close · 6 Oct 2026
4 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹11,461 CrMarket cap
56.5P/E (TTM)
39.5%Delivery

Filings & corporate actions

31 results filed
CSV
Next results · Q2 FY27
Expected 4 Nov 2026 – 11 Nov 2026
Estimate: filed 35–42 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 19 May 2026
2026
  • 4 AugresultsResults · Q1 FY27 · consolidated and standalone-1.3%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-0.9%NSE
  • 19 MaydividendDividend · ₹1.00 per share+0.2%
  • 13 MayresultsResults · Q4 FY26 · consolidated and standalone-1.3%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+1.9%NSE
  • 1 AprshareholdingShareholding · 23 Mar 2026-2.2%NSE
  • 20 MarbonusBonus issue · factor 4.00-3.3%
  • 4 FebresultsResults · Q3 FY26 · consolidated and standalone+4.0%NSE
  • 20 JanshareholdingShareholding · 31 Dec 20250.0%NSE

Reaction to results · all yearsrose on day 0 in 14 of 30 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY274 Aug 2026-1.3%-5.5%-0.4%0.9×
Q4 FY2613 May 2026-1.3%-3.5%-3.2%4.2×
Q3 FY264 Feb 2026+4.0%+4.8%-5.6%9.9×
Q2 FY264 Nov 2025-1.2%-3.2%-4.9%3.5×
Q1 FY267 Aug 2025+0.7%+8.7%+6.8%0.3×
Q4 FY2513 May 2025-5.1%-2.3%-0.8%8.2×
Q3 FY254 Feb 2025+3.9%+0.7%-5.1%4.7×
Q2 FY258 Nov 2024+1.9%-4.5%+5.1%2.7×
Q1 FY2510 Aug 2024-0.9%+1.6%+5.5%1.8×
Q4 FY2422 May 2024-0.5%-1.8%-0.8%0.9×
Q3 FY243 Feb 2024+1.8%+1.8%+3.8%0.9×
Q2 FY245 Nov 2023+6.7%+10.0%+13.4%3.2×
Q1 FY243 Aug 2023-3.4%-2.0%-2.1%1.5×
Q4 FY2317 May 2023-4.3%-3.3%+1.9%2.6×
Q3 FY2310 Feb 2023+2.0%+5.6%-4.4%3.1×
Q2 FY239 Nov 2022-6.0%-16.7%-16.7%1.9×
Q1 FY2311 Aug 2022-1.7%-6.9%-1.3%2.4×
Q4 FY2225 May 2022+2.8%+0.2%-10.0%2.7×
Q3 FY2212 Feb 2022-15.3%-18.4%-22.6%8.6×
Q2 FY2211 Nov 2021-2.6%-0.2%+2.2%1.5×
Q1 FY227 Aug 2021-3.3%-7.5%-0.3%1.5×
Q4 FY2128 May 2021+9.8%+10.0%+28.5%25.2×
Q3 FY2111 Feb 2021-3.8%-6.3%-11.0%1.2×
Q2 FY2113 Nov 2020+2.2%+19.7%+4.7%0.7×
Q1 FY2112 Aug 2020+0.7%+6.3%+9.7%3.6×
Q4 FY2030 May 2020+1.7%+5.1%-1.9%1.5×
Q3 FY208 Feb 2020-2.6%+5.4%+4.8%1.0×
Q2 FY2013 Nov 2019-0.1%+2.9%-7.7%1.6×
Q1 FY208 Aug 2019+0.8%-2.1%+18.6%0.6×
Q4 FY1915 May 2019+2.0%+4.7%+6.3%—
Average-0.4%+0.1%+0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+16.6%
Profit YoY+25.7%
Interest cost YoY+33.5%
Revenue QoQ+6.0%
Profit QoQ+11.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+17.2%+14.3%+9.7%+7.7%+13.6%—
Profit+21.4%+13.5%+4.0%-4.5%+11.9%—

Key data

CSV
Open565.35
Day range537.60 – 565.35
52-week range412.25 – 609.05
From 52w high-9.3%
RSI (14)40.9
ATR (14)18.95
Volume3.68L
Avg volume (20D)2.48L
Rel volume1.48×
Volatility (1Y)29.3%
Turnover₹20.3Cr
SMA 50 / 200573.78 / 516.58

Delivery percentage

Latest · 6 Oct 202639.5%
20-day avg56.4%
1-year avg53.2%
Percentile (own history)46th
Range4.8–95.1%
Sessions1,731

Over the last 20 sessions METROPOLIS settled 56.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.2%, so recent sessions are running 3.2 points higher than usual. The latest session ranks higher than 46% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Service Provider
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-0.17%-3.43%-6.63%-2.38%+31.04%+9.73%

Valuation

CSV
Market cap₹11,461 Cr
P/E (TTM)56.5
EPS (TTM)9.78
Shares outstanding20.73Cr
Listed15 Apr 2019

Ownership

CSV
Promoter48.86%
Promoter Δ QoQ-0.01 pp
Public51.14%
FII11.03%
DII35.12%
Pledged1.18%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)429.2405.9424.7450.2
YoY chg+22.7%+25.8%+23.0%+16.6%
Net profit (₹ Cr)52.942.151.056.9
YoY chg+13.3%+33.7%+74.3%+25.7%
Net margin12.3%10.4%12.0%12.6%
EPS2.531.992.462.73

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 48.86% · public 51.14%
30 Sept 2021: promoter 50.33%31 Dec 2021: promoter 49.50%31 Mar 2022: promoter 49.79%30 Jun 2022: promoter 49.79%30 Sept 2022: promoter 49.76%31 Dec 2022: promoter 49.76%31 Mar 2023: promoter 49.75%30 Jun 2023: promoter 49.75%30 Sept 2023: promoter 49.74%31 Dec 2023: promoter 49.74%31 Mar 2024: promoter 49.67%30 Jun 2024: promoter 49.62%30 Sept 2024: promoter 49.43%31 Dec 2024: promoter 49.40%31 Mar 2025: promoter 48.90%30 Jun 2025: promoter 48.89%30 Sept 2025: promoter 48.89%31 Dec 2025: promoter 48.88%23 Mar 2026: promoter 48.87%31 Mar 2026: promoter 48.87%30 Jun 2026: promoter 48.86%
2021-092026-06
  • Promoter
  • Public and others
Promoter
48.86%
Public
51.14%
Promoter change
-0.01 pp
Filed
21 Jul 2026
FII
11.03%
DII
35.12%
Promoter pledged
1.18%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations308.5291.1331.0313.4349.8322.8345.3386.1429.2405.9424.7450.2
Other income1.22.32.52.53.12.67.07.50.99.08.25.1
Total income309.7293.4333.5315.8352.9325.3352.3393.6430.1414.9432.8455.3
Total expenses261.6256.6283.0264.7291.5283.0316.2332.3359.1348.7363.2377.6
└ Finance costs5.75.35.64.74.84.54.65.25.75.77.96.2
└ Depreciation22.225.026.425.526.827.728.630.832.431.938.632.4
Profit before tax48.136.950.551.161.442.336.061.271.057.269.877.7
Tax expense12.59.614.013.014.710.96.816.018.115.118.820.8
Net profit35.727.336.538.146.731.529.245.252.942.151.056.9
EPS1.731.321.781.852.271.531.422.172.542.002.462.73
Net margin11.56%9.37%11.04%12.16%13.35%9.75%8.47%11.72%12.32%10.37%12.00%12.63%
PBT margin15.60%12.66%15.27%16.30%17.55%13.12%10.44%15.86%16.55%14.08%16.43%17.26%
Tax rate25.88%25.96%27.72%25.39%23.94%25.65%18.90%26.11%25.53%26.37%26.95%26.80%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 4 Aug 2026.

METROPOLIS at a glance

  • METROPOLIS closed at ₹552.65 on 6 Oct 2026, -0.17% on the day, +9.7% over one year, 9.3% below its 52-week high of ₹609.05.
  • Delivery was 39.5% of traded quantity on 6 Oct 2026, the 46th percentile of its own 1,731 sessions with a reading (20-session average 56.4%, 1-year average 53.2%).
  • Market capitalisation is ₹11,461 crore at a trailing P/E of 56.5 (trailing EPS ₹9.78).
  • Q1 FY27 results (consolidated, filed 4 Aug 2026): revenue ₹450 crore (+16.6% year on year), net profit ₹57 crore (+25.7%); the price moved -1.3% on the first session after.
  • Promoters held 48.86% at 30 Jun 2026, down 0.01 percentage points on the previous filing, with 1.18% of promoter shares pledged.
  • Q2 FY27 results are expected between 4 Nov 2026 and 11 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHealthcare Service Provider
ISININE112L01020
SeriesEQ
Listed15 Apr 2019
History from15 Apr 2019
Sessions1,849
Turnover rank#909

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE